Pulmatrix
Pulmatrix, Inc.: A US-based biotech firm specializing in therapies for chronic respiratory diseases.
- 24
- Public company
- Framingham, MA, USUnited States
Pulmatrix, Inc. is a clinical stage biotechnology company focused on developing innovative therapies for chronic respiratory diseases. Their primary areas of research include cystic fibrosis, obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The company utilizes its proprietary iSPERSE™ technology to create pulmonary-delivered therapeutics, aiming to revolutionize patient care for those with serious respiratory conditions.
Based in Lexington, United States, Pulmatrix is committed to expanding treatment horizons for individuals affected by severe respiratory diseases. The company's pioneering approach to drug delivery through the lungs represents a significant advancement in the field of respiratory medicine, potentially offering new hope for patients with limited therapeutic options.
Similar Companies
Aer Therapeutics
Lung Biotechnology
unither.com
Pulmotect
pulmotect.com
Pulmonx
pulmonx.com
Pneuma Respiratory
Spyryx Biosciences
Parion Sciences
parion.com
Alveolus Bio
alveolusbio.com
Respira Therapeutics
Metera Pharmaceuticals
Inception Sciences
PulmonIx
pulmonix.com
Avalyn Pharma
avalynpharma.com
Bellerophon Therapeutics be
bellerophon.com
Insmed
insmed.com
Synspira
Theron Pharmaceuticals
Respirics
Orpro Therapeutics
FibrosIX
Quick Facts
Who are Pulmatrix's competitors?
Companies similar to Pulmatrix include Aer Therapeutics, Lung Biotechnology, Pulmotect and Pulmonx.
When was Pulmatrix founded?
Pulmatrix was founded in 2003.
Where is Pulmatrix's headquarters located?
Pulmatrix's headquarters is located in Framingham, MA, US.
When was Pulmatrix's last funding round?
Pulmatrix's most recent funding round was for $1M (USD) in March 2026.
How much disclosed funding has Pulmatrix raised?
As of Mar 26, 2026, Pulmatrix has disclosed funding of $149.4M (USD). Undisclosed round amounts are excluded.
How many employees does Pulmatrix have?
Pulmatrix has 24 employees as of Feb 6, 2024.
Classification
- Industry
- Ownership
- Technology
- Geographic Exposure
- Revenue
- Customer
- Main Product
- Tags
- Also Known As
- Pulmatrix, Inc.
- Headquarters
- 945 Concord Street
- Suite 1217
- Framingham, MA, 01701
- US
- Ticker
- PULM
- SEC CIK
- 0001574235
- EIN
- 46-1821392
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 2800Chemicals And Allied Products
- 2830Drugs
- 2834Pharmaceutical Preparations
- ISIC
- 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
- Industry
- —Biotechnology Companies
- —Health Care Companies
- —Medical Organizations
- —Pharmaceutical Companies
Show 18 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 541910Marketing Research and Public Opinion Polling
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 623000Nursing and Residential Care Facilities
- 541900Other Professional, Scientific, and Technical Services
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 8732Commercial Economic, Sociological, And Educational Research
- 4000Railroad Transportation
- 8000Health Services
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8040Offices And Clinics Of Other Health Practitioners
- 8730Research, Development, And Testing Services
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
- 8731Commercial Physical and Biological Research
- ISIC
- 7320Market research and public opinion polling